German biotech opens US office to expand its global presence
Sirion Biotech has opened a US-based office to support local gene therapy research and clinical development with viral vector contract manufacturing.
Archives for February 5, 2019
Exclusive interview
QPS triples translational medicine capacity to support gene therapy demand
QPS is expanding ‘aggressively’ at its US-based headquarters, rebuilding on a rolling basis to support a growing demand for gene therapy treatments, says VP.
Lonza collaborates on commercial supply manufacturing for anti-coagulation antidote
Portola and Lonza will collaborate on commercial supply the API for the former’s anti-coagulation antidote at Lonza’s facilities.
US FDA to publish additional guidance to ‘genericize’ complex drugs
As complex drugs see little competition, the FDA will distribute guidelines to increase approvals of generic medicines for ‘economic stability’ and to bring affordable drugs to patients.
eClinical firm YPrime secures ‘significant’ PE investment
The cloud-based eClinical solutions company today announced that it has received a significant investment from Flexpoint Ford, a Chicago-based private equity (PE) firm.
Aetion expanding RWE platform backed by $63m investment
Aetion aims to advance the adoption of and standards for real-world evidence backed by a strategic investment from several global biopharma and health care companies.